• Skip to main content
  • Skip to navigation
  • Accessibility
  • Contact Us
Government of Western Australia Crest
Government of Western Australia
Government of Western Australia Crest

Additional Menu

  • Accessibility
  • Contact us
Go to WA Government search
  • About us
    • Our Vision and Values
    • Strategic Plan
    • Our Team
      • Health Service Board
    • Customer Service
      • Provide Your Feedback
      • Customer Service Charter
      • Freedom of Information
      • Public Interest Disclosure
      • Quality Management
    • Work With Us
      • Vacancies
      • Pathways to Working With Us
      • Diversity and Inclusion
    • Research & Partnerships
    • Education
      • HLT37215 Certificate III in Pathology Collection
    • Annual Reports
    • Contact us
    • Locations
  • Our Services
    • Clinical Services
      • Anatomical Pathology
      • Biochemistry
      • Diagnostic Genomics
      • Forensic Services
      • Haematology & Blood Transfusion
      • Immunology
      • Microbiology
      • Point-of-Care Testing
    • Commercial Services
      • Food and Water Testing
      • Health & Workplace Testing
      • Media Manufacturing
      • Pharmaceutical Testing
      • Request a Quote
      • Resources
    • Perinatal Pathology
      • Information for Families
      • Information for Health Professionals
      • Information for Funeral Directors
    • PCH Mortuary
      • Information for Families
      • Information for Health Professionals
    • Clinical Trials and Research
    • State Mortuary Bereavement Centre
  • For Health Professionals
    • Service Updates
    • Test Directory and Resources
    • Requesting Pathology
    • Respiratory Pathogen Dashboard
    • Results
    • Staff
  • Electronic Results Delivery
  • For Patients
    • Find a Collection Centre
    • Infant and Child Tests
    • Preparing for Your Test
    • Measles
    • Mpox (monkeypox)
    • Pay a Bill
      • Hospital Inpatients
      • Medicare Rebates
    • Your Results
    • Your Safety
  • Latest News
  1. Home
  2. Latest News

Latest News

Latest News

  • International Women’s Day - Balancing the Scales 08 March 2026 Today on International Women’s Day we celebrate the significant contributions of women across PathWest. From our diagnostic labs to our leadership teams, their expertise and dedication are integral to providing high-quality pathology services that support the WA health system. At PathWest, we don't just celebrate women; we empower them. We are proud to share that: 74.4% of our workforce comprises women. For the first time since becoming a Health Service Provider in 2018, we are led by our first female Chief Executive and Chief Pathologist. Women make up 50% of our Health Executive Service and approximately 50% of Tier 4 leadership positions. Representation remains strong in the lab, with over 50% of our pathologists and high-level Medical and Principal Scientists in Charge being women. With this year’s theme, Balance the Scales, we continue to build a safe...
  • Shaping the Future: PathWest Welcomes our 2026 Registrar Intake 06 March 2026 PathWest is proud to welcome our latest intake of Registrars. As WA's only public pathology provider, we are committed to investing in the clinical leaders of tomorrow and supporting a positive workplace culture that encourages both personal wellbeing and professional excellence for our Registrars during that journey. We currently have66 Registrarsacross our service, including12 new starterswho jo...
  • Beyond the Diagnosis: PathWest in global mission to ‘find the match’ 28 February 2026 On Rare Disease Day (28 February), we reflect on the global effort to improve equity in diagnosis and treatment for those living with rare conditions. In WA, this mission is powered by PathWest. An example is Department of Immunology at Fiona Stanley Hospital — providing life-saving stem cell tissue typing for patients facing rare blood diseases. Using high-resolution next generation DNA Sequenci...
  • PathWest’s Zo Ee Wong awarded prestigious FHRI grant for groundbreaking immunotherapy research 20 February 2026 We are thrilled to announce that our very own Zo Ee Wong from the Department of Clinical Immunology FSH has been awarded a Clinician Researcher Training grant through the Future Health Research and Innovation (FHRI) Fund and The Hospital Research Foundation Group for her innovative CAR T cell immunotherapy research to improve outcomes for patients with blood cancers. Zo Ee is one of only eight We...
  • International Acclaim for PathWest Forensic Biology staff 05 February 2026 A publication co-authored by PathWest Forensic Biology staff members Anna Heavey (Senior Forensic Scientist in Charge-Quality, Training, Safety & Risk) and Gavin Turbett (Head of Department) has been selected as a 2025 Noteworthy Article for the prestigious Journal of Forensic Sciences. The Journal of Forensic Sciences is the official publication of the American Academy of Forensic Sciences, whic...

Read more news

  • Biochemistry FSH Consultant Chemical Pathologist becomes the Editor-in-Chief of RCPA’s Journal 15 March 2024 Congratulations to Dr John Burnett on his appointment as the new Editor-in-Chief of the Royal College of Pathologists of Australasia (RCPA) Pathology Journal, announced at the RCPA Pathology Update 2024 Editorial Board Meeting. Read RCPA’s post on LinkedIn for more information.
  • Rare Disease Day 2024 15 March 2024 Rare Disease Day is celebrated globally on 29 February 2024 raising awareness to improve the access to diagnosis and treatment for those living with a rare disease, their families and carers. At PathWest, we have organised a number of events to acknowledge the significance of this day, highlighting the outstanding work of our teams in paving the way for scientific advancement, treatment and a brighter future for those affected by rare diseases. Joined by our guest speaker, Andrew Bannister, Ambassador of Rare Voices Australia, our Chief Executive Dr Narelle Hadlow, Board Chair Ms Angie Paskevicius, Diagnostic Genomics Head of Department Dr Dimitar Azmanov, Board Member Mr Tony Vis, Acting Chief Pathologist Dr David Smith, Biochemistry QEII Head of Department Dr Simon Carrivick and other PathWest staff, we not only recognise the rarity of these diseases but also the strength, courage, a...
  • Immunosuppressant service changes to 7 days per week starting on 7 January 2024 06 February 2024 PathWest has commenced the seven-day-per-week immunosuppressant service. Registrars will be exempt from the obligation to contact the on-call pathologists at PathWest to obtain authorisation to send samples on weekends.To facilitate an efficient workflow and assure prompt delivery of service, please note the following sample processing times and kindly distribute this information to other staff members. To obtain same day results (by 4 pm) for Tacrolimus, Sirolimus, Everolimus, and Cyclosporin test requests, samples must be received in testing laboratory (CBPT, QEII MC, Level 1, PP Block, Hospital Avenue, Nedlands, WA 6009): Monday - Saturday by 2pm, and Sundays/public holidays by 1pm. Please note: Specimens received after 2pm Monday – Saturday and after 1pm Sundays and public holidays will be assayed and reported the following day Critically urgent Tacrolimus ...
  • Pioneering cancer advancements - PathWest's collaborative initiatives on World Cancer Day 05 February 2024 World Cancer Day, observed annually on 4 February, serves as a reminder of the global collaboration essential in the ongoing battle against cancer. At the forefront of this collaborative effort is the PathWest Community Health and Hospital Program, spearheading a $19 million initiative in Western Australia dedicated to Comprehensive Genomic Profiling (CGP) for all cancer patients. This ground-breaking endeavour leverages state-of-the-art massively parallel sequencing technology, marking a significant stride in the pursuit of advanced cancer diagnosis and treatment. CGP is an integral aspect of the program which serves as a transformative tool that identifies biomarkers, guiding tailored treatment strategies and instilling hope for those facing exhaustive conventional treatment options. The program's commitment extends to ensuring equitable cancer care for all Western Australian patients...
  • Sampling time recommendations for mast cell tryptase in association with suspected event causing mast cell activation 22 December 2023 This service update is regarding PathWest sampling time recommendations for mast cell tryptase in association with a suspected event causing mass cell activation (e.g. anaphylaxis). The changes are in line with sampling times recommended in UK and Australian guidelines published by the Australian and New Zealand Anaesthetic Allergy Group (ANZAAG), National Institute for Health and Care Excellence (NICE) and British Society of Allergy & Clinical Immunology (BSACI). Sample collections for mast cell tryptase are now recommended to be taken: Close to 1-2 hours after the event (no later than 4 hours), and At least 24 hours after the event to obtain a baseline level. These recommendations are now updated on the PathWest Test Directory. Download an information flyer. Please contact the Immunology support team for more information on (08) 6383 4303.
Previous12345678910...22Next
Last Updated: 20/05/2025
  • Facebook
  • LinkedIn

Footer menu

  • wa.gov.au
  • Copyright
  • Disclaimer
  • Privacy
  • Sitemap
  • Contact Us

Brought to you by the Department of Health, Western Australia

© Government of Western Australia 2018 to